Status:
COMPLETED
Examination of Ocular Surface Effects With Administration of Travatan Z and XALATAN
Lead Sponsor:
Alcon Research
Conditions:
Open-angle Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare two ophthalmic solutions in patients with open-angle glaucoma or ocular hypertension.
Eligibility Criteria
Inclusion
- 18 years or older.
- Diagnosis of open-angle glaucoma or ocular hypertension in at least one eye.
- Intraocular pressure (IOP) controlled with BAK (benzalkonium chloride) preserved IOP-lowering medication for 1 year, with last 6 months on XALATAN® monotherapy.
- Best corrected visual acuity of -0.6 logMAR or better in each eye.
- Other protocol-defined inclusion criteria may apply.
Exclusion
- Treatment with BAK preserved artificial tears within 30 days of Visit 1.
- Known or suspected Sjogren's disease.
- Uncontrolled IOP.
- History or evidence of infectious or inflammatory ocular conditions.
- Progressive retinal or optic nerve disease.
- Ocular laser surgery within 3 months of Visit 1.
- Keratorefractive ocular laser procedures, corneal surgery or surgery to the corneal surface within 1 year of Visit 1.
- Current use of punctal plugs or punctal cautery.
- Use of systemic medications that has not been stable for 30 days prior to Visit 1.
- Use of contact lens within 30 days of Visit 1.
- Other protocol-defined exclusion criteria may apply.
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
236 Patients enrolled
Trial Details
Trial ID
NCT00798759
Start Date
December 1 2008
End Date
May 1 2009
Last Update
June 1 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.